160
Participants
Start Date
April 30, 2008
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
FlutiForm 250/10 ug
SKP FlutiForm 250/10ug is a HFA pMDI that delivers 125ug of Fluticasone propionate per actuation and 5ug of Formoterol fumarate per actuation. Patients will take 2 actuations BID for 6 weeks.
FlutiForm 100/10 ug
SKP FlutiForm 100/10ug is a HFA pMDI that delivers 50ug of Fluticasone propionate per actuation and 5ug of Formoterol fumarate per actuation. Patients will take 2 actuations BID for 6 weeks.
Oral Prednisone 10mg
2 x 5 mg oral prednisone tablets, over encapsulated, once a day for one week.
Placebo
2 x 5 mg placebo tablets, over encapsulated, once a day for six weeks. SKP FlutiForm placebo HFA pMDI. Two actuations BID for six weeks.
Investigational Site, Pasadena
Investigational site, Spartanburg
Investigational site, DeLand
Investigational site, Omaha
Investigational site, New Braunfels
Investigational site, San Antonio
Investigational site, El Paso
Investigational site, Centennial
Investigational site, Denver
Investigational site, Lakewood
Investigational site, Colorado Springs
Investigational site, Phoenix
Investigational site, Long Beach
Investigational site, San Diego
Investigational site, Anaheim
Investigational Site, Lake Oswego
Investigational site, Portland
Investigational site, North Dartmouth
Investigational site, Skillman
Collaborators (1)
Abbott
INDUSTRY
SkyePharma AG
INDUSTRY